Citigroup’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$145K Sell
21,016
-16,813
-44% -$116K ﹤0.01% 3499
2025
Q1
$109K Sell
37,829
-11,893
-24% -$34.3K ﹤0.01% 3789
2024
Q4
$234K Sell
49,722
-24,981
-33% -$117K ﹤0.01% 3499
2024
Q3
$267K Buy
74,703
+51,912
+228% +$185K ﹤0.01% 3391
2024
Q2
$141K Sell
22,791
-155,773
-87% -$966K ﹤0.01% 3332
2024
Q1
$1.69M Sell
178,564
-106,734
-37% -$1.01M ﹤0.01% 1958
2023
Q4
$1.93M Buy
285,298
+196,109
+220% +$1.32M ﹤0.01% 1674
2023
Q3
$396K Buy
89,189
+81,286
+1,029% +$361K ﹤0.01% 2581
2023
Q2
$26.1K Buy
7,903
+6,193
+362% +$20.4K ﹤0.01% 4214
2023
Q1
$4.87K Sell
1,710
-43
-2% -$123 ﹤0.01% 4256
2022
Q4
$12.8K Sell
1,753
-167
-9% -$1.22K ﹤0.01% 4056
2022
Q3
$16K Sell
1,920
-1,820
-49% -$15.2K ﹤0.01% 4090
2022
Q2
$18K Sell
3,740
-25,488
-87% -$123K ﹤0.01% 4358
2022
Q1
$691K Sell
29,228
-11,205
-28% -$265K ﹤0.01% 2637
2021
Q4
$715K Buy
40,433
+33,118
+453% +$586K ﹤0.01% 2834
2021
Q3
$206K Buy
7,315
+396
+6% +$11.2K ﹤0.01% 3369
2021
Q2
$73K Buy
6,919
+5,178
+297% +$54.6K ﹤0.01% 3974
2021
Q1
$21K Sell
1,741
-1,851
-52% -$22.3K ﹤0.01% 4554
2020
Q4
$42K Buy
3,592
+2,905
+423% +$34K ﹤0.01% 4209
2020
Q3
$5K Sell
687
-1,050
-60% -$7.64K ﹤0.01% 4653
2020
Q2
$32K Sell
1,737
-1,942
-53% -$35.8K ﹤0.01% 3967
2020
Q1
$44K Buy
3,679
+2,767
+303% +$33.1K ﹤0.01% 3868
2019
Q4
$15K Buy
912
+673
+282% +$11.1K ﹤0.01% 4589
2019
Q3
$2K Buy
+239
New +$2K ﹤0.01% 4959